A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Clinical trial NCT01174004 · COMPLETED
Trial details
- NCT number
- NCT01174004
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-11-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.